These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35018443)

  • 41. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Letter to the Editor From Nelson et al: "Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response".
    Nelson K; Prior JC; Kalidasan D; Tanenbaum C; Shirin S; Berger C; Goshtasebi A
    J Clin Endocrinol Metab; 2022 Dec; 108(1):e11-e12. PubMed ID: 36268884
    [No Abstract]   [Full Text] [Related]  

  • 43. Reply to Letter to the Editor Re: Liu et al., Pregnancy Outcomes During the COVID-19 Pandemic in Canada, March to August 2020.
    Liu S; Dzakpasu S; Nelson C; Wei SQ; Little J; Scott H; Joseph KS
    J Obstet Gynaecol Can; 2022 Jan; 44(1):9-10. PubMed ID: 35033336
    [No Abstract]   [Full Text] [Related]  

  • 44. Emerging pulmonary histopathological findings in COVID-19 patients- a letter to the editor in response to Grosse et al. 2020.
    Parmar D; Ponnampalam J; Seligmann G; Gandhi T
    Cardiovasc Pathol; 2021; 51():107302. PubMed ID: 33152459
    [No Abstract]   [Full Text] [Related]  

  • 45. Response to Letter to the Editor From Nelson et al: "Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response".
    Foulkes AS; Selvaggi C; Shinnick D; Lumish H; Cao T; Thaweethai T; Qian J; Meigs JB; Triant VA; Bassett IV; Reilly MP
    J Clin Endocrinol Metab; 2022 Dec; 108(1):e13. PubMed ID: 36300318
    [No Abstract]   [Full Text] [Related]  

  • 46. Authors' reply to the letter to the editor from Castagna et al.
    Maki Y; Sano T; Kimizuka Y; Kawana A
    Geriatr Gerontol Int; 2021 Apr; 21(4):372. PubMed ID: 33576124
    [No Abstract]   [Full Text] [Related]  

  • 47. Covid-19 and Diabetes Mellitus.
    Attri B; Gupta Y; Tandon N
    Natl Med J India; 2021; 34(3):129-131. PubMed ID: 34825533
    [No Abstract]   [Full Text] [Related]  

  • 48. Diabetes and COVID-19: Population Impact 18 Months Into the Pandemic.
    Gregg EW; Sophiea MK; Weldegiorgis M
    Diabetes Care; 2021 Sep; 44(9):1916-1923. PubMed ID: 34244333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
    Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
    Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes Mellitus and COVID-19: Review Article.
    Nassar M; Daoud A; Nso N; Medina L; Ghernautan V; Bhangoo H; Nyein A; Mohamed M; Alqassieh A; Soliman K; Alfishawy M; Sachmechi I; Misra A
    Diabetes Metab Syndr; 2021; 15(6):102268. PubMed ID: 34562865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Letter to the editor regarding the article by Naylor et al. in the February 2022 issue of Radiography.
    Dean V
    Radiography (Lond); 2022 Aug; 28(3):869-870. PubMed ID: 35331636
    [No Abstract]   [Full Text] [Related]  

  • 53. Letter to the editor RE: Fulford et al., 2021 'A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2'.
    Lake DF; Roeder AJ; Seit-Nebi A; Gonzalez-Moa MJ; Svarovsky S
    EBioMedicine; 2022 Mar; 77():103898. PubMed ID: 35220041
    [No Abstract]   [Full Text] [Related]  

  • 54. No Role for Reintroducing OPV into the United States with Respect to Controlling COVID-19 [Response to the letter to the Editor by Chumakov et al.].
    Thompson KM; Kalkowska DA; Badizadegan K
    Risk Anal; 2021 Feb; 41(2):389-392. PubMed ID: 33590518
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter to the Editor From Raven et al: "Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine".
    Raven LM; McCormack AI; Greenfield JR
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1767-e1768. PubMed ID: 34752614
    [No Abstract]   [Full Text] [Related]  

  • 56. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
    Singh AK; Singh R
    Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
    Vaishya R; Bahl S; Singh RP
    Diabetes Metab Syndr; 2020; 14(4):687-688. PubMed ID: 32442918
    [No Abstract]   [Full Text] [Related]  

  • 58. Re: "
    Rani R
    Assay Drug Dev Technol; 2021 Oct; 19(7):408-409. PubMed ID: 34463124
    [No Abstract]   [Full Text] [Related]  

  • 59. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.
    Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X
    Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response to Letter to the editor: Lung Ultrasound in COVID-19 Patients - More Shadows Than Information - Letter to the Editor on the Article "W. LU et al. Ultraschall in Med. 2020 Apr 15".
    Wuzhu L; Shushan Z; Binghui C; Jiaxin C; Jianzhong X; Yuhong L; Hong S; Zhong Zhen S
    Ultraschall Med; 2020 Aug; 41(4):441-442. PubMed ID: 32588412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.